DuPont Decomposition

Why does AAREYDRUGS earn its ROE?

Breaking down Return on Equity into profitability, efficiency, and leverage.

ROE = Net Margin × Asset Turnover × Equity Multiplier

2.9% = 0.8% × 1.63 × 2.10

Latest: FY2025

Profitability

Net Margin

0.8%

1.3% →0.8%

How much profit per ₹ of revenue

Efficiency

Asset Turnover

1.63x

2.01x →1.63x

Revenue per ₹ of assets

Leverage

Equity Multiplier

2.10x

2.16x →2.10x

Assets funded by equity vs debt

Trend Analysis

ROE declined by 2.9 pp over 4 years. Driven by asset turnover declining (2.01x → 1.63x).

Historical Decomposition

Last 4 years

YearRevenuePATNet MarginAsset TOLeverageROE
FY20220Cr0Cr1.3%2.012.165.8%
FY20230Cr0Cr0.9%1.422.483.2%
FY20240Cr0Cr1.2%1.302.283.5%
FY20250Cr0Cr0.8%1.632.102.9%

How to read DuPont

  • Rising ROE from margin = pricing power, operational improvement (good)
  • Rising ROE from turnover = better asset utilization (good)
  • Rising ROE from leverage = more debt, amplified risk (caution)
  • Falling ROE across all three = structural deterioration (red flag)

See DCF fair value for AAREYDRUGS

Combine financial quality with intrinsic value.

See Fair Value →

DuPont decomposition from audited annual financials. Factual analysis, not investment advice.

AAREYDRUGS DuPont Analysis — ROE 2.9% | YieldIQ